Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa.


Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
14 Jul 2021
Historique:
received: 24 06 2020
accepted: 05 07 2021
entrez: 15 7 2021
pubmed: 16 7 2021
medline: 17 7 2021
Statut: epublish

Résumé

In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide. Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak. Full genomes sequences of six Tunisian SARS-CoV-2 strains were obtained from imported and locally transmission cases during the COVID-19 outbreak. Reported sequences were non-identical with 0.1% nucleotide divergence rate and clustered into 6 different clades with worldwide sequences. SNPs results favor the distribution of the reported Tunisian sequences into 3 major genotypes. These SNP mutations are critical for diagnosis and vaccine development. These results indicate multiple introductions of the virus in Tunisia and add new genomic data on SARS-CoV-2 at the international level.

Sections du résumé

BACKGROUND BACKGROUND
In Tunisia a first SARS-CoV-2 confirmed case was reported in March 03, 2020. Since then, an increase of cases number was observed from either imported or local cases. The aim of this preliminary study was to better understand the molecular epidemiology and genetic variability of SARS-CoV-2 viruses circulating in Tunisia and worldwide.
METHODS METHODS
Whole genome sequencing was performed using NGS approach on six SARS. CoV-2 highly positive samples detected during the early phase of the outbreak.
RESULTS RESULTS
Full genomes sequences of six Tunisian SARS-CoV-2 strains were obtained from imported and locally transmission cases during the COVID-19 outbreak. Reported sequences were non-identical with 0.1% nucleotide divergence rate and clustered into 6 different clades with worldwide sequences. SNPs results favor the distribution of the reported Tunisian sequences into 3 major genotypes. These SNP mutations are critical for diagnosis and vaccine development.
CONCLUSIONS CONCLUSIONS
These results indicate multiple introductions of the virus in Tunisia and add new genomic data on SARS-CoV-2 at the international level.

Identifiants

pubmed: 34261445
doi: 10.1186/s12864-021-07870-1
pii: 10.1186/s12864-021-07870-1
pmc: PMC8278182
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

540

Subventions

Organisme : European Commission
ID : DEVCO: IFS/2018/402-247)

Informations de copyright

© 2021. The Author(s).

Références

J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
J Med Virol. 2020 Jun;92(6):667-674
pubmed: 32167180
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265007
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Genomics. 2020 Sep;112(5):3588-3596
pubmed: 32353474
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945

Auteurs

Wasfi Fares (W)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia. fwasfi@yahoo.fr.

Anissa Chouikha (A)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Kais Ghedira (K)

Laboratory of Bioinformatics, Biomathematics and Biostatistics (BIMS), Institut Pasteur Tunis, Tunis, Tunisia.

Meriam Gdoura (M)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Dorra Rezig (D)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Sondes Haddad Boubaker (SH)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Imen Ben Dhifallah (IB)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Henda Touzi (H)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Walid Hammami (W)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Zina Meddeb (Z)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Amel Sadraoui (A)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Nahed Hogga (N)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Imen Abouda (I)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.

Aurélia Kwasiborski (A)

Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France.

Véronique Hourdel (V)

Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France.

Guillain Mikaty (G)

Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France.

Valérie Caro (V)

Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France.

Jean-Claude Manuguerra (JC)

Laboratory for Urgent Response to Biological Threats (CIBU), Environment and Infectious Risks (ERI) research and expertise unit, Institut Pasteur, Paris, France.

Nissaf Ben Alaya (NB)

National Observatory for New and Emerging Diseases, Ministry of Health, Tunis, Tunisia.
Faculty of Medicine, University Tunis-El Manar, Tunis, Tunisia.

Henda Triki (H)

Laboratory of Clinical Virology, Institut Pasteur, University Tunis-El Manar, Tunis, Tunisia.
Faculty of Medicine, University Tunis-El Manar, Tunis, Tunisia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH